Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Dec;65(12):4937–4942. doi: 10.1128/iai.65.12.4937-4942.1997

Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis.

M L Rodrigues 1, S Rozental 1, J N Couceiro 1, J Angluster 1, C S Alviano 1, L R Travassos 1
PMCID: PMC175712  PMID: 9393779

Abstract

Sialic acids from sialoglycoconjugates present at the cell surface of Cryptococcus neoformans yeast forms were analyzed by high-performance thin-layer chromatography, binding of influenza A and C virus strains, enzymatic treatment, and flow cytofluorimetry with fluorescein isothiocyanate-labeled lectins. C. neoformans yeast forms grown in a chemically defined medium contain N-acetylneuraminic acid and its 9-O-acetylated derivative. A density of 3 x 10(6) residues of sialic acid per cell was found in C. neoformans. Sialic acids in cryptococcal cells are glycosidically linked to galactopyranosyl units as inferred from the increased reactivity of neuraminidase-treated yeasts with peanut agglutinin. N-Acetylneuraminic acids are alpha-2,6 and alpha-2,3 linked, as indicated by using virus strains M1/5 and M1/5 HS8, respectively, as agglutination probes. The alpha-2,6 linkage markedly predominated. These findings were essentially confirmed by the interaction of cryptococcal cells with the lectins Sambucus nigra agglutinin and Maackia amurensis agglutinin. We also investigated whether the sialyl residues present in C. neoformans are involved in the fungal interaction with a cationic solid-phase substrate and with mouse resident macrophages. Adhesion of yeast cells to poly-L-lysine was mediated, in part, by sialic acid residues, since the number of adherent cells was markedly reduced after treatment with bacterial neuraminidase. The enzymatic removal of sialic acids also made C. neoformans yeast cells more susceptible to endocytosis by macrophages. The results show that sialic acids are components of the cryptococcal cell surface that contribute to its negative charge and protect yeast forms against phagocytosis.

Full Text

The Full Text of this article is available as a PDF (199.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhattacharjee A. K., Bennett J. E., Glaudemans C. P. Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis. 1984 Sep-Oct;6(5):619–624. doi: 10.1093/clinids/6.5.619. [DOI] [PubMed] [Google Scholar]
  2. Bolaños B., Mitchell T. G. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol. 1989;27(4):203–217. [PubMed] [Google Scholar]
  3. Butterfield W., Jong S. C. Effect of carbon source on conidiogenesis in Fonsecaea dermatitidis, agent of chromomycosis. Mycopathologia. 1976 Jun 4;58(1):59–62. doi: 10.1007/BF00493594. [DOI] [PubMed] [Google Scholar]
  4. Cherniak R. Soluble polysaccharides of Cryptococcus neoformans. Curr Top Med Mycol. 1988;2:40–54. doi: 10.1007/978-1-4612-3730-3_2. [DOI] [PubMed] [Google Scholar]
  5. Cherniak R., Sundstrom J. B. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun. 1994 May;62(5):1507–1512. doi: 10.1128/iai.62.5.1507-1512.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Couceiro J. N., Paulson J. C., Baum L. G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 1993 Aug;29(2):155–165. doi: 10.1016/0168-1702(93)90056-s. [DOI] [PubMed] [Google Scholar]
  7. Dykstra M. A., Friedman L., Murphy J. W. Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect Immun. 1977 Apr;16(1):129–135. doi: 10.1128/iai.16.1.129-135.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edwards M. S., Kasper D. L., Jennings H. J., Baker C. J., Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol. 1982 Mar;128(3):1278–1283. [PubMed] [Google Scholar]
  9. Farhi F., Bulmer G. S., Tacker J. R. Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast. Infect Immun. 1970 Jun;1(6):526–531. doi: 10.1128/iai.1.6.526-531.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hamilton A. J., Jeavons L., Hobby P., Hay R. J. A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope. Infect Immun. 1992 Jan;60(1):143–149. doi: 10.1128/iai.60.1.143-149.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. James P. G., Cherniak R., Jones R. G., Stortz C. A., Reiss E. Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr Res. 1990 Apr 2;198(1):23–38. doi: 10.1016/0008-6215(90)84273-w. [DOI] [PubMed] [Google Scholar]
  12. Kozel T. R. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans. Infect Immun. 1983 Mar;39(3):1214–1219. doi: 10.1128/iai.39.3.1214-1219.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kozel T. R., Reiss E., Cherniak R. Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide. Infect Immun. 1980 Aug;29(2):295–300. doi: 10.1128/iai.29.2.295-300.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lee H. Y., Kelm S., Michalski J. C., Schauer R. Influence of sialic acids on the galactose-recognizing receptor of rat peritoneal macrophages. Biol Chem Hoppe Seyler. 1990 Apr;371(4):307–316. doi: 10.1515/bchm3.1990.371.1.307. [DOI] [PubMed] [Google Scholar]
  15. Levitz S. M. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991 Nov-Dec;13(6):1163–1169. doi: 10.1093/clinids/13.6.1163. [DOI] [PubMed] [Google Scholar]
  16. Maresca B., Medoff G., Schlessinger D., Kobayashi G. S. Regulation of dimorphism in the pathogenic fungus Histoplasma capsulatum. Nature. 1977 Mar 31;266(5601):447–448. doi: 10.1038/266447a0. [DOI] [PubMed] [Google Scholar]
  17. Mitchell T. G., Perfect J. R. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995 Oct;8(4):515–548. doi: 10.1128/cmr.8.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moran A. P., Rietschel E. T., Kosunen T. U., Zähringer U. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol. 1991 Jan;173(2):618–626. doi: 10.1128/jb.173.2.618-626.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Muchmore E. A., Varki A. Selective inactivation of influenza C esterase: a probe for detecting 9-O-acetylated sialic acids. Science. 1987 Jun 5;236(4806):1293–1295. doi: 10.1126/science.3589663. [DOI] [PubMed] [Google Scholar]
  20. Murphy J. W. Cryptococcal immunity and immunostimulation. Adv Exp Med Biol. 1992;319:225–230. doi: 10.1007/978-1-4615-3434-1_23. [DOI] [PubMed] [Google Scholar]
  21. Nagura H., Asai J., Katsumata Y., Kojima K. Role of electric surface charge of cell membrane in phagocytosis. Acta Pathol Jpn. 1973 May;23(2):279–290. doi: 10.1111/j.1440-1827.1973.tb00792.x. [DOI] [PubMed] [Google Scholar]
  22. Neilson J. B., Fromtling R. A., Bulmer G. S. Cryptococcus neoformans: size range of infectious particles from aerosolized soil. Infect Immun. 1977 Sep;17(3):634–638. doi: 10.1128/iai.17.3.634-638.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nosanchuk J. D., Casadevall A. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun. 1997 May;65(5):1836–1841. doi: 10.1128/iai.65.5.1836-1841.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Oda L. M., Kubelka C. F., Alviano C. S., Travassos L. R. Ingestion of yeast forms of Sporothrix schenckii by mouse peritoneal macrophages. Infect Immun. 1983 Feb;39(2):497–504. doi: 10.1128/iai.39.2.497-504.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Orendi J. M., Verheul A. F., De Vos N. M., Visser M. R., Snippe H., Cherniak R., Vaishnav V. V., Rijkers G. T., Verhoef J. Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication. Clin Exp Immunol. 1997 Feb;107(2):293–299. doi: 10.1111/j.1365-2249.1997.283-ce1169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reuter G., Schauer R. Determination of sialic acids. Methods Enzymol. 1994;230:168–199. doi: 10.1016/0076-6879(94)30012-7. [DOI] [PubMed] [Google Scholar]
  27. Ribeiro S., Alviano C. S., Silva-Filho F. C., da Silva E. F., Angluster J., de Souza W. Sialic acid is a cell surface component of Entamoeba invadens trophozoites. Microbios. 1989;57(231):121–129. [PubMed] [Google Scholar]
  28. Rogers G. N., Herrler G., Paulson J. C., Klenk H. D. Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem. 1986 May 5;261(13):5947–5951. [PubMed] [Google Scholar]
  29. Schauer R. Chemistry, metabolism, and biological functions of sialic acids. Adv Carbohydr Chem Biochem. 1982;40:131–234. doi: 10.1016/s0065-2318(08)60109-2. [DOI] [PubMed] [Google Scholar]
  30. Schauer R., Reuter G., Mühlpfordt H., Andrade A. F., Pereira M. E. The occurrence of N-acetyl- and N-glycoloylneuraminic acid in Trypanosoma cruzi. Hoppe Seylers Z Physiol Chem. 1983 Aug;364(8):1053–1057. doi: 10.1515/bchm2.1983.364.2.1053. [DOI] [PubMed] [Google Scholar]
  31. Seed T. M., Aikawa M., Sterling C., Rabbege J. Surface properties of extracellular malaria parasites: morphological and cytochemical study. Infect Immun. 1974 Apr;9(4):750–761. doi: 10.1128/iai.9.4.750-761.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Soares R. M., Alviano C. S., Angluster J., Travassos L. R. Identification of sialic acids on the cell surface of hyphae and yeast forms of the human pathogen Paracoccidioides brasiliensis. FEMS Microbiol Lett. 1993 Mar 15;108(1):31–34. doi: 10.1016/0378-1097(93)90483-i. [DOI] [PubMed] [Google Scholar]
  33. Souza E. T., Silva-Filho F. C., De Souza W., Alviano C. S., Angluster J., Travassos L. R. Identification of sialic acids on the cell surface of hyphae and conidia of the human pathogen Fonsecaea pedrosoi. J Med Vet Mycol. 1986 Apr;24(2):145–154. doi: 10.1080/02681218680000211. [DOI] [PubMed] [Google Scholar]
  34. Travassos L. R., Cury R. Thermophilic enteric yeasts. Annu Rev Microbiol. 1971;25:49–74. doi: 10.1146/annurev.mi.25.100171.000405. [DOI] [PubMed] [Google Scholar]
  35. Turner S. H., Cherniak R., Reiss E. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res. 1984 Feb 15;125(2):343–349. doi: 10.1016/0008-6215(84)85172-1. [DOI] [PubMed] [Google Scholar]
  36. Varki A. Diversity in the sialic acids. Glycobiology. 1992 Feb;2(1):25–40. doi: 10.1093/glycob/2.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Varki A. Sialic acids as ligands in recognition phenomena. FASEB J. 1997 Mar;11(4):248–255. doi: 10.1096/fasebj.11.4.9068613. [DOI] [PubMed] [Google Scholar]
  38. WARREN L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959 Aug;234(8):1971–1975. [PubMed] [Google Scholar]
  39. Wessels M. R., Rubens C. E., Benedí V. J., Kasper D. L. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8983–8987. doi: 10.1073/pnas.86.22.8983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wickes B. L., Mayorga M. E., Edman U., Edman J. C. Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7327–7331. doi: 10.1073/pnas.93.14.7327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zimmer G., Reuter G., Schauer R. Use of influenza C virus for detection of 9-O-acetylated sialic acids on immobilized glycoconjugates by esterase activity. Eur J Biochem. 1992 Feb 15;204(1):209–215. doi: 10.1111/j.1432-1033.1992.tb16626.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES